HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tuixent Escribà Selected Research

Inflammation (Inflammations)

11/2018Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tuixent Escribà Research Topics

Disease

1Acquired Immunodeficiency Syndrome (AIDS)
12/2018
1Atherosclerosis
11/2018
1Inflammation (Inflammations)
11/2018
1Disease Progression
01/2016
1Dyslipidemias (Dyslipidemia)
02/2013
1Coinfection
02/2013
1HIV Infections (HIV Infection)
01/2012
1Coronary Disease (Coronary Heart Disease)
01/2012
1Hypertension (High Blood Pressure)
01/2012
1Diabetes Mellitus
01/2012

Drug/Important Bio-Agent (IBA)

1catechol (pyrocatechol)IBA
12/2018
1IronIBA
12/2018
1LigandsIBA
12/2018
1PolymersIBA
12/2018
1CholesterolIBA
11/2018
1Antiviral Agents (Antivirals)IBA
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1oxidized low density lipoproteinIBA
02/2013
1Lipoprotein(a)IBA
01/2012
1Genetic Markers (Genetic Marker)IBA
01/2012
1Biomarkers (Surrogate Marker)IBA
01/2012

Therapy/Procedure

2Therapeutics
12/2018 - 02/2013
1Art Therapy
02/2013